血栓通透性与MeVO卒中IVT及EVT疗效差异相关
该单中心回顾性队列研究纳入255例中等血管闭塞卒中患者,评估血栓通透性指数(TPI)与治疗方式的交互作用。结果显示TPI与治疗方式存在显著交互:高TPI患者接受IVT更易获得90天功能独立,而低TPI患者接受EVT可能相对更有优势。
要点
- MeVO卒中患者中,TPI与治疗方式对90天功能独立存在显著交互作用。
- 高TPI患者接受IVT的功能独立几率更高,而接受EVT的几率更低。
- 低TPI患者可能从EVT中相对获益,高TPI患者可能从IVT中相对获益。
核心结论
- 在中等血管闭塞卒中中,血栓通透性与治疗结局相关,高通透性 favoring IVT相关获益,而低通透性血栓患者使用EVT可能相对更有优势。
研究设计与样本
- 单中心回顾性队列研究,纳入2018至2024年中国一家卒中中心影像确诊的中等血管闭塞患者255例(154例IVT,101例EVT伴或不伴先前IVT)。
- 血栓通透性通过非增强CT和CT血管造影计算的血栓通透性指数(TPI)量化。
- 采用多变量逻辑回归和逆概率治疗加权评估TPI与治疗方式对90天功能独立(改良Rankin量表评分≤2)的交互作用。
主要发现
- IVT组与EVT组90天功能独立率相似(51.9% versus 51.5%;P=0.96),TPI与结局无独立关联。
- 在逆概率治疗加权模型中,TPI与治疗方式存在显著交互(交互OR 0.37 [95%CI 0.24-0.56];P<0.001)。
- IVT治疗患者中,TPI每增加0.05单位,功能独立几率更高(OR 1.73 [95%CI 1.19-2.53];P=0.005)。
- EVT治疗患者中,TPI每增加0.05单位,功能独立几率更低(OR 0.65 [95%CI 0.49-0.87];P=0.003)。
- IVT亚组探索性分析显示功能独立随TPI增加而持续增加,无稳定截断值;症状性颅内出血和90天死亡率组间无差异,TPI与出血风险无关。
临床怎么用
- 对于中等血管闭塞卒中患者,可参考血栓通透性指数(TPI)辅助选择再灌注治疗策略。
- 高TPI患者可能优先考虑静脉溶栓(IVT),低TPI患者可能从血管内治疗(EVT)中相对获益。
局限性
- 单中心回顾性队列研究,样本量255例,结论需外部验证。
- IVT亚组中TPI与功能独立的关联为探索性分析,未确定稳定截断值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In acute ischemic stroke due to medium vessel occlusion, the relative effectiveness of intravenous thrombolysis (IVT) and endovascular therapy (EVT) remains controversial, and treatment benefits may vary across patients. We evaluated the interaction between thrombus perviousness and treatment modality on 90-day functional outcome in patients with medium vessel occlusion. METHODS: This single-center retrospective cohort study analyzed 255 patients with imaging-confirmed medium vessel occlusion treated at a stroke center in China between 2018 and 2024 (154 IVT and 101 EVT with or without prior IVT). Thrombus perviousness was quantified using the thrombus perviousness index (TPI) from noncontrast computed tomography and computed tomography angiography. Multivariable logistic regression and inverse probability of treatment weighting evaluated the TPI-by-treatment interaction for 90-day functional independence (modified Rankin Scale score ≤2). Sensitivity analyses used alternative weighting strategies and a surrogate thrombus perviousness measure. RESULTS: The 90-day functional independence rate was similar between the IVT and EVT groups (51.9% versus 51.5%; P=0.96), and TPI was not independently associated with outcome. In the inverse probability of treatment weighting-weighted model, a significant interaction between TPI and treatment modality was observed (interaction odds ratio, 0.37 [95% CI, 0.24-0.56]; P<0.001). Higher TPI was associated with a greater likelihood of functional independence in IVT-treated patients (odds ratio per 0.05-unit increase, 1.73 [95% CI, 1.19-2.53]; P=0.005), but lower odds in EVT-treated patients (odds ratio, 0.65 [95% CI, 0.49-0.87]; P=0.003). Exploratory analyses in the IVT subgroup revealed a continuous increase in functional independence as TPI increased, without a stable cutoff. Rates of symptomatic intracranial hemorrhage and 90-day mortality did not differ between groups, and TPI was not associated with hemorrhage risk. CONCLUSIONS: In medium vessel occlusion, thrombus perviousness was associated with treatment outcomes, with higher perviousness favoring IVT-related benefits, whereas the use of EVT may be relatively advantageous in patients with low-perviousness thrombi.
引用
- Zhang M, Wu X, Qu Y, et al. Thrombus Perviousness Is Associated With Differential Treatment Outcomes Following IVT and EVT in MeVO Stroke. Stroke. 2026. PMID: 42605684. doi:10.1161/STROKEAHA.126.055948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。